Topics:
- How CAR T-cell therapy is reshaping treatment for blood cancers
- Side-effect management
- The next generation of CAR T-cell therapies
Program Materials
Speaker
Vu Nguyen, MD
Director, Center of Excellence for Leukemia and Lymphoma, East Bay
Director, CAR-T Cell Therapy Program, Northern California
Kaiser Permanente
Oakland, CA
Program Support
Support for this program provided by Autolus Therapeutics plc, Bristol Myers Squibb, Johnson & Johnson & Legend Biotech, Kite, a Gilead Company, and Novartis Pharmaceuticals Corporation.